GNPX is the ticker symbol for Genprex, Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks GNPX with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is GNPX a good stock to buy?

GNPX is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/GNPX.

Where does 13F Pro source GNPX data?

All Genprex, Inc. fundamentals and ownership data come directly from SEC EDGAR. Genprex, Inc. files with the SEC under CIK 1595248. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Genprex, Inc. GNPX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026

$155.0K total

VANGUARD FIDUCIARY TRUST CO

$40.5KNew

HRT FINANCIAL LP

$37.0KNew

GEODE CAPITAL MANAGEMENT, LLC

$31.3K+80.8%

VANGUARD CAPITAL MANAGEMENT LLC

$18.9K+510.9%

Engineers Gate Manager LP

$10.8KNew

Mayflower Financial Advisors, LLC

$10.4K0.0%

UBS Group AG

$2.3KNew

Tower Research Capital LLC (TRC)

$1.5KNew

BARCLAYS PLC

$819New

JONES FINANCIAL COMPANIES LLLP

$597-42.6%

Cheviot Value Management, LLC

$5190.0%

BlackRock, Inc.

$980.0%

HARBOUR INVESTMENTS, INC.

$56-10.0%

OSAIC HOLDINGS, INC.

$41-64.7%

SBI Securities Co., Ltd.

$250.0%

Bernard Wealth Management Corp.

$16-85.0%

Allworth Financial LP

$12+666.7%

Integrated Wealth Concepts LLC

$11New

HighMark Wealth Management LLC

$50.0%

Nemes Rush Group LLC

$30.0%

MORGAN STANLEY

$30.0%

Bogart Wealth, LLC

$10.0%

Global Retirement Partners, LLC

$1--

JPMORGAN CHASE & CO

$10.0%

Caitong International Asset Management Co., Ltd

$1-50.0%

See all 28 institutional holders →

Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/GNPX

Loading ratio trend…

GNPX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Confer Ryan M.President, CEO and CFOShares withheld for tax or exercise price · Feb 27, 2026
Berger Mark StanleyChief Medical OfficerShares withheld for tax or exercise price · Feb 27, 2026
Wilson William R Jr.DirectorGrant or award · Dec 22, 2025
Longnecker Brent MDirectorGrant or award · Dec 22, 2025
Moreno Toscano Jose AntonioDirectorGrant or award · Dec 22, 2025

About Genprex, Inc. (GNPX): stock profile, AI score and financials

Genprex, Inc. (GNPX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GNPX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of GNPX by reported 13-F value include VANGUARD FIDUCIARY, HRT FINANCIAL, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. GNPX trades on the Nasdaq exchange and files with the SEC under CIK 1595248. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GNPX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Genprex, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1595248 →